• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同浓度烟酰胺对培养的造血干细胞的影响

Effects of different concentrations of nicotinamide on hematopoietic stem cells cultured .

作者信息

Ren Yan, Cui Yan-Ni, Wang Hong-Wei

机构信息

The Second Clinical Medical College, Shanxi Medical University, Taiyuan 030001, Shanxi Province, China.

Department of Hematology, The Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China.

出版信息

World J Stem Cells. 2024 Feb 26;16(2):163-175. doi: 10.4252/wjsc.v16.i2.163.

DOI:10.4252/wjsc.v16.i2.163
PMID:38455103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10915957/
Abstract

BACKGROUND

expansion to increase numbers of hematopoietic stem cells (HSCs) in cord blood could improve clinical efficacy of this vital resource. Nicotinamide (NAM) can promote HSC expansion , but its effect on hematopoietic stem and progenitor cells (HSPCs, CD34CD38) and functional subtypes of HSCs - short-term repopulating HSCs (ST-HSCs, CD34CD38CD45RACD49f) and long-term repopulating HSCs (LT-HSCs, CD34CD38CD45RACD49fCD90) is not yet known. As a sirtuin 1 (SIRT1) inhibitor, NAM participates in regulating cell adhesion, polarity, migration, proliferation, and differentiation. However, SIRT1 exhibits dual effects by promoting or inhibiting differentiation in different tissues or cells. We propose that the concentration of NAM may influence proliferation, differentiation, and SIRT1 signaling of HSCs.

AIM

To evaluate the effects and underlying mechanisms of action of different concentrations of NAM on HSC proliferation and differentiation.

METHODS

CD34 cells were purified from umbilical cord blood using MacsCD34 beads, and cultured for 10-12 d in a serum-free medium supplemented with cytokines, with different concentrations of NAM added according to experimental requirements. Flow cytometry was used to detect phenotype, cell cycle distribution, and apoptosis of the cultured cells. Real-time polymerase chain reaction was used to detect the transcription levels of target genes encoding stemness-related factors, chemokines, components of hypoxia pathways, and antioxidant enzymes. Dichloro-dihydro-fluorescein diacetate probes were used to evaluate intracellular production of reactive oxygen species (ROS). Determination of the effect of different culture conditions on the balance of cytokine by cytometric bead array.

RESULTS

Compared with the control group, the proportion and expansion folds of HSPCs (CD34CD38) incubated with 5 mmol/L or 10 mmol/L NAM were significantly increased (all < 0.05). The ST-HSCs ratio and fold expansion of the 5 mmol/L NAM group were significantly higher than those of the control and 10 mmol/L NAM groups (all < 0.001), whereas the LT-HSCs ratio and fold expansion of the 10 mmol/L NAM group were significantly higher than those of the other two groups (all < 0.05). When the NAM concentration was > 10 mmol/L, cell viability significantly decreased. In addition, compared with the 5 mmol/L NAM group, the proportion of apoptotic cells in the 10 mmol/L NAM group increased and the proportion of cells in S and G2 phase decreased. Compared with the 5 mmol/L NAM group, the HSCs incubated with 10 mmol/L NAM exhibited significantly inhibited SIRT1 expression, increased intracellular ROS content, and downregulated expression of genes encoding antioxidant enzymes (superoxide dismutase 1, peroxiredoxin 1).

CONCLUSION

Low concentrations (5 mmol/L) of NAM can better regulate the balance between proliferation and differentiation, thereby promoting expansion of HSCs. These findings allow adjustment of NAM concentrations according to expansion needs.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ad8/10915957/05a74432bc0b/WJSC-16-163-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ad8/10915957/582cc4f3e7a2/WJSC-16-163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ad8/10915957/5838ab60cc9b/WJSC-16-163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ad8/10915957/b8024482dcf7/WJSC-16-163-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ad8/10915957/05a74432bc0b/WJSC-16-163-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ad8/10915957/582cc4f3e7a2/WJSC-16-163-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ad8/10915957/5838ab60cc9b/WJSC-16-163-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ad8/10915957/b8024482dcf7/WJSC-16-163-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ad8/10915957/05a74432bc0b/WJSC-16-163-g004.jpg
摘要

背景

扩大脐血中造血干细胞(HSC)的数量可提高这种重要资源的临床疗效。烟酰胺(NAM)可促进造血干细胞扩增,但其对造血干祖细胞(HSPC,CD34⁺CD38⁻)以及造血干细胞的功能亚型——短期重建造血干细胞(ST-HSC,CD34⁺CD38⁻CD45RA⁻CD49f⁺)和长期重建造血干细胞(LT-HSC,CD34⁺CD38⁻CD45RA⁻CD49f⁺CD90⁺)的影响尚不清楚。作为一种沉默调节蛋白1(SIRT1)抑制剂,NAM参与调节细胞黏附、极性、迁移、增殖和分化。然而,SIRT1在不同组织或细胞中通过促进或抑制分化表现出双重作用。我们推测NAM的浓度可能影响造血干细胞的增殖、分化和SIRT1信号传导。

目的

评估不同浓度NAM对造血干细胞增殖和分化的影响及其潜在作用机制。

方法

使用Macs CD34磁珠从脐血中纯化CD34⁺细胞,并在补充细胞因子的无血清培养基中培养10 - 12 d,根据实验要求添加不同浓度的NAM。采用流式细胞术检测培养细胞的表型、细胞周期分布和凋亡情况。使用实时聚合酶链反应检测编码干性相关因子、趋化因子、缺氧途径成分和抗氧化酶的靶基因的转录水平。使用二氯二氢荧光素二乙酸酯探针评估细胞内活性氧(ROS)的产生。通过细胞计数珠阵列测定不同培养条件对细胞因子平衡的影响。

结果

与对照组相比,用5 mmol/L或10 mmol/L NAM孵育的HSPC(CD34⁺CD38⁻)比例和扩增倍数显著增加(均P<0.05)。5 mmol/L NAM组的ST-HSC比例和扩增倍数显著高于对照组和10 mmol/L NAM组(均P<0.001),而10 mmol/L NAM组的LT-HSC比例和扩增倍数显著高于其他两组(均P<0.05)。当NAM浓度>10 mmol/L时,细胞活力显著下降。此外,与5 mmol/L NAM组相比,10 mmol/L NAM组凋亡细胞比例增加,S期和G2期细胞比例下降。与5 mmol/L NAM组相比,用10 mmol/L NAM孵育的造血干细胞SIRT1表达显著受抑制,细胞内ROS含量增加,编码抗氧化酶(超氧化物歧化酶1、过氧化物还原酶1)的基因表达下调。

结论

低浓度(5 mmol/L)的NAM能更好地调节增殖与分化之间的平衡,从而促进造血干细胞的扩增。这些发现有助于根据扩增需求调整NAM浓度。

相似文献

1
Effects of different concentrations of nicotinamide on hematopoietic stem cells cultured .不同浓度烟酰胺对培养的造血干细胞的影响
World J Stem Cells. 2024 Feb 26;16(2):163-175. doi: 10.4252/wjsc.v16.i2.163.
2
Synergistic effect and molecular mechanism of nicotinamide and UM171 in expansion of long-term hematopoietic stem cells.烟酰胺与UM171在长期造血干细胞扩增中的协同作用及分子机制
Regen Ther. 2024 Mar 27;27:191-199. doi: 10.1016/j.reth.2024.03.011. eCollection 2024 Dec.
3
Synergistic effect and molecular mechanism of PVA and UM171 in ex vivo expansion of primitive hematopoietic stem cells.PVA 和 UM171 在原代造血干细胞体外扩增中的协同作用及分子机制。
J Cell Biochem. 2024 Jan;125(1):79-88. doi: 10.1002/jcb.30505. Epub 2023 Nov 22.
4
Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftment.烟酰胺,一种 SIRT1 抑制剂,可抑制分化并促进造血祖细胞的扩增,增强骨髓归巢和植入。
Exp Hematol. 2012 Apr;40(4):342-55.e1. doi: 10.1016/j.exphem.2011.12.005. Epub 2011 Dec 20.
5
Differential ability of MSCs isolated from placenta and cord as feeders for supporting ex vivo expansion of umbilical cord blood derived CD34(+) cells.从胎盘和脐带分离的间充质干细胞作为饲养层支持脐血来源的CD34(+)细胞体外扩增的差异能力。
Stem Cell Res Ther. 2015 Oct 19;6:201. doi: 10.1186/s13287-015-0194-y.
6
A small-molecule/cytokine combination enhances hematopoietic stem cell proliferation via inhibition of cell differentiation.一种小分子/细胞因子组合通过抑制细胞分化增强造血干细胞增殖。
Stem Cell Res Ther. 2017 Jul 18;8(1):169. doi: 10.1186/s13287-017-0625-z.
7
Ex vivo expansion and functional activity preservation of adult hematopoietic stem cells by a diarylheptanoid from Curcuma comosa.莪术二芳基庚烷对成体造血干细胞的体外扩增及功能活性保存作用
Biomed Pharmacother. 2021 Nov;143:112102. doi: 10.1016/j.biopha.2021.112102. Epub 2021 Aug 30.
8
Expansion and preservation of the functional activity of adult hematopoietic stem cells cultured ex vivo with a histone deacetylase inhibitor.使用组蛋白去乙酰化酶抑制剂体外培养成年造血干细胞时其功能活性的扩展与保存
Stem Cells Transl Med. 2020 Apr;9(4):531-542. doi: 10.1002/sctm.19-0199. Epub 2020 Jan 17.
9
UM171 promotes expansion of autologous peripheral blood hematopoietic stem cells from poorly mobilizing lymphoma patients.UM171 可促进动员效果不佳的淋巴瘤患者自体外周血造血干细胞的扩增。
Int Immunopharmacol. 2020 Apr;81:106266. doi: 10.1016/j.intimp.2020.106266. Epub 2020 Feb 12.
10
Ex vivo expansion of human hematopoietic stem cells by a small-molecule agonist of c-MPL.通过c-MPL的小分子激动剂对人造血干细胞进行体外扩增。
Exp Hematol. 2009 Nov;37(11):1364-1377.e4. doi: 10.1016/j.exphem.2009.09.001. Epub 2009 Sep 8.

引用本文的文献

1
Culturing Potential: advances in ex vivo cell culture systems for haematopoietic cell-based regenerative therapies.培养潜力:用于基于造血细胞的再生疗法的体外细胞培养系统的进展
Regen Ther. 2025 Jul 17;30:403-414. doi: 10.1016/j.reth.2025.07.001. eCollection 2025 Dec.
2
Exploring the potential of predicted miRNAs on the genes involved in the expansion of hematopoietic stem cells.探索预测 microRNAs 在参与造血干细胞扩增的基因中的作用。
Sci Rep. 2024 Jul 5;14(1):15551. doi: 10.1038/s41598-024-66614-9.

本文引用的文献

1
Synergistic effect and molecular mechanism of PVA and UM171 in ex vivo expansion of primitive hematopoietic stem cells.PVA 和 UM171 在原代造血干细胞体外扩增中的协同作用及分子机制。
J Cell Biochem. 2024 Jan;125(1):79-88. doi: 10.1002/jcb.30505. Epub 2023 Nov 22.
2
Expansion strategies for umbilical cord blood haematopoietic stem cells in vitro.脐带血造血干细胞的体外扩增策略
Vox Sang. 2023 Nov;118(11):913-920. doi: 10.1111/vox.13505. Epub 2023 Oct 13.
3
The Antioxidant TEMPOL Protects Human Hematopoietic Stem Cells From Culture-Mediated Loss of Functions.
抗氧化剂 TEMPOL 可保护人造血干细胞免受培养介导的功能丧失。
Stem Cells Transl Med. 2023 Oct 5;12(10):676-688. doi: 10.1093/stcltm/szad049.
4
Chemically defined cytokine-free expansion of human haematopoietic stem cells.人造血干细胞的化学定义无细胞因子扩增
Nature. 2023 Mar;615(7950):127-133. doi: 10.1038/s41586-023-05739-9. Epub 2023 Feb 22.
5
Differential CXCR4 expression on hematopoietic progenitor cells versus stem cells directs homing and engraftment.造血祖细胞与干细胞上 CXCR4 的差异表达指导归巢和植入。
JCI Insight. 2022 May 9;7(9):e151847. doi: 10.1172/jci.insight.151847.
6
SRT1720 inhibits the growth of bladder cancer in organoids and murine models through the SIRT1-HIF axis.SRT1720 通过 SIRT1-HIF 轴抑制类器官和小鼠模型中的膀胱癌生长。
Oncogene. 2021 Oct;40(42):6081-6092. doi: 10.1038/s41388-021-01999-9. Epub 2021 Sep 1.
7
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study.Omidubicel 与标准清髓性脐带血移植的比较:一项 3 期随机研究结果。
Blood. 2021 Oct 21;138(16):1429-1440. doi: 10.1182/blood.2021011719.
8
Ex vivo expansion of hematopoietic stem cells: Finally transitioning from the lab to the clinic.体外扩增造血干细胞:终于从实验室走向临床。
Blood Rev. 2021 Nov;50:100853. doi: 10.1016/j.blre.2021.100853. Epub 2021 Jun 4.
9
Nicotinamide riboside attenuates age-associated metabolic and functional changes in hematopoietic stem cells.烟酰胺核糖苷可减轻造血干细胞与年龄相关的代谢和功能变化。
Nat Commun. 2021 May 11;12(1):2665. doi: 10.1038/s41467-021-22863-0.
10
Effect of Small Molecule on Expansion of Cord Blood Hematopoietic Stem Cells: A Concise Review.小分子对脐血造血干细胞扩增的影响:简要综述
Front Cell Dev Biol. 2021 Apr 9;9:649115. doi: 10.3389/fcell.2021.649115. eCollection 2021.